Product Information

BUPRENORPHINE 5 MCG/HR PATCH is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $23.8187 per EA under NDC 69238120202. Its NADAC has been published 319 times since Jul 15, 2020.

FDA first approved this application on Apr 14, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE 5 MCG/HR PATCH

Buprenorphine
$23.8187per EA
DEA Schedule CIII

Strength

5 ug/h

NDC

69238120202

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Effective Date

8/19/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211586

FDA Approved

4/14/2020

TE Code

AB

On Market Since

4/20/2020

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE 5 MCG/HR PATCH has been published 319 times since Jul 15, 2020, and over the history we have for it it has declined 49.9%. The table below summarizes its recorded NADAC range and movement.

Current price$23.8187 per EA
All-time high$50.9220 (Aug 11, 2021)
All-time low$19.0169 (May 22, 2024)
52-week high$23.9718
52-week low$20.8287
Median price$29.8801
Average price$31.9679
Largest weekly change-32.9% (Jun 21, 2023)
Weeks tracked319
Tracking sinceJul 15, 2020

Price History

1W

+3.9%

1M

+3.9%

3M

+4.5%

6M

+13.8%

1Y

+11.0%

3Y

-21.8%

5Y

-52.2%

All

-49.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE 5 MCG/HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 5 MCG/HR PATCH, manufactured by Amneal Pharmaceuticals NY LLC, is $23.8187 per EA (NDC 69238120202), effective Aug 19, 2026.

How has the price of BUPRENORPHINE 5 MCG/HR PATCH changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has declined 49.9%. It has been tracked across 319 weekly CMS publications since Jul 15, 2020.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 5 MCG/HR PATCH?

Since Jul 15, 2020, the NADAC for BUPRENORPHINE 5 MCG/HR PATCH has ranged from a low of $19.0169 (May 22, 2024) to a high of $50.9220 (Aug 11, 2021), with a median of $29.8801 per EA.

Are there cheaper alternatives to BUPRENORPHINE 5 MCG/HR PATCH?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE 5 MCG/HR PATCH?

BUPRENORPHINE 5 MCG/HR PATCH (NDC 69238120202) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.